-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Verve Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2019 to Q1 2025.
- Verve Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $1.22M, a 183% increase year-over-year.
- Verve Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $3.74M, a 59.8% decline from 2023.
- Verve Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $9.28M, a 29.8% decline from 2022.
- Verve Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $13.2M, a 204% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)